CXCL9 and colorectal carcinoma: It is possible that in human CRC that are microsatellite stable, blockade of IL-17 can also result in increased production of CXCL9 family chemokines and enhanced infiltration of CD8+ T cells to tumors, which is a desirable trait for cancer immunotherapy.